Llwytho...

Role of rituximab in first-line treatment of chronic lymphocytic leukemia

Chronic lymphocytic leukemia (CLL) is a biologically heterogeneous illness that primarily afflicts the elderly. For many decades, the initial therapy for most patients requiring treatment was limited to single-agent alkylator therapy. Within the last two decades, we have seen remarkable progress in...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Bryan, Jeffrey, Borthakur, Gautam
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Dove Medical Press 2011
Pynciau:
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3039008/
https://ncbi.nlm.nih.gov/pubmed/21339937
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S5855
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!